IRVINE, Calif.--(BUSINESS WIRE)--PhageTech, Inc. today announced that it has raised $2.4 million in Series A funding from a group of early stage investors co-led by Mark IV Capital and Black River Investments. Proceeds will be used to complete development and FDA clearance of its revolutionary PhageTech Biosensor™ technology.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
